1. Medtech Insight
  2. >>Business
  3. >>Deals

Covidien Further Bulks Up Vascular Biz With Sapheon Buy

Just one week after inking a deal to buy neurovascular product firm Reverse Medical, Covidien announced the purchase of another vascular device maker, Sapheon, which focuses on venous disease treatments.

In its second move in a week to beef up its vascular offerings, Medtronic Minimally Invasive Therapies said Aug. 28 it has bought venous disease device firm Sapheon Inc. for an undisclosed amount.

Sapheon is the Morrisville, North Carolina-based privately held developer of VenaSeal system, which uses a specially formulated medical adhesive to close the great saphenous vein in patients with varicose veins...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business

Salvia Bioelectronics Secures $60M In Series B To Advance Chronic Migraine Implant, Eyes US Trials

 
• By Marion Webb

Medtech Insight spoke with Hubert Martens, CEO of Netherlands-based neuromodulation company Salvia Bioelectronics, about the company’s innovative implant for treating chronic migraines, ongoing clinical trials and plans for US clinical trials and commercialization.

Industry Execs Talk Tariff Turbulence During MD&M East

 
• By Brian Bossetta

During MD&M East in Manhattan last week, a panel of experts discussed how the Trump administration’s trade policy is affecting manufacturing and offered some ideas on what manufacturers can do to help mitigate the chaos.

Bone Surgery Startup Surgify Medical Raises $7.9m

 
• By Natasha Barrow

Surgify Medical’s selective drill tip, Surgify Halo, is “an obvious choice for surgeons,” said Boris Hofmann, head of ZEISS Ventures and lead investor in the company’s series A funding round.